| Pharmaceutical Information |
| Drug Name |
Hydroxyproline |
| Drug ID |
BADD_D01108 |
| Description |
Hydroxyproline is a neutral heterocyclic protein amino acid. It is found in collagen and as such it is common in many gelatin products. Hydroxyproline is mostly used as a diagnostic marker of bone turnover and liver fibrosis. Therapeutically, hydroxyproline is being studied as an an experimental medicine but is approved in France as a combination topical gel product called Cicactive for small, superficial wounds. |
| Indications and Usage |
Used in France as a combination product for the treatment of small, superficial wounds. |
| Marketing Status |
experimental |
| ATC Code |
Not Available |
| DrugBank ID |
DB08847
|
| KEGG ID |
Not Available
|
| MeSH ID |
D006909
|
| PubChem ID |
5810
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| UNII |
RMB44WO89X
|
| Synonyms |
Hydroxyproline | 4-Hydroxyproline | 4 Hydroxyproline | Oxyproline | cis-4-Hydroxyproline | cis 4 Hydroxyproline |
|
| Chemical Information |
| Molecular Formula |
C5H9NO3 |
| CAS Registry Number |
618-28-0 |
| SMILES |
C1C(CNC1C(=O)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Rash | 23.03.13.001 | - | - | Not Available | | Skin irritation | 23.03.04.009 | - | - | Not Available |
|
The 1th Page
1
Total 1 Pages
|
|
